Sienna Biopharmaceuticals Overview
- Founded
-
2010

- Status
-
Public
- Employees
-
39

- Stock Symbol
-
SNNAQ

- Investments
-
1
Sienna Biopharmaceuticals General Information
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Contact Information
Website
www.siennabio.com
Formerly Known As
Sienna Labs
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
PINX
Primary Office
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
+1 (818) 000-0000
Sienna Biopharmaceuticals Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
44.8K |
Sienna Biopharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Sep-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
---|---|---|---|---|
EV | (13,007) | 15,053 | 287,833 | |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (52,417) | (73,314) | (50,715) | (21,095) |
Net Income | (47,951) | (73,471) | (50,545) | (21,162) |
Total Assets | 43,492 | 107,306 | 136,847 | 62,377 |
Total Debt | 0 | 30,125 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Sienna Biopharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sienna Biopharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Sienna Biopharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechno
Pharmaceuticals
Westlake Village, CA
39
As of 2019
00000
0000000000.
Sienna Biopharmaceuticals Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Harrow Health | Corporate Backed or Acquired | Nashville, TN | 000 | 000.00 | 000000000 | 000.00 |
00000000 | Formerly VC-backed | Alameda, CA | 000 | 00000 | 000000000 | 00000 |
Sienna Biopharmaceuticals Patents
Sienna Biopharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190209472-A1 | Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure | Abandoned | 04-Dec-2017 | 00000000 | |
EP-3621657-A1 | Uses of polymer conjugates of indolocarbazole compounds with reduced exposure | Withdrawn | 10-May-2017 | 000000000 | |
EP-3600440-A1 | Reduced exposure conjugates modulating therapeutic targets | Withdrawn | 20-Mar-2017 | 000000000 | |
US-20180071024-A1 | Enhanced efficacy and targeted topical delivery of drugs to skin with nanoparticles | Abandoned | 20-Mar-2015 | 0000000000 | |
EP-3071211-A1 | Metastable silver nanoparticle composites with color indicating properties | Withdrawn | 18-Nov-2013 | A61L15/56 |
Sienna Biopharmaceuticals Executive Team (18)
Sienna Biopharmaceuticals Board Members (15)
Name | Representing | Role | Since |
---|---|---|---|
Dennis Fenton Ph.D | Self | Board Member | 000 0000 |
Donna Janson | Self | Board Member | 000 0000 |
Frederick Beddingfield III | Sienna Biopharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
James Hindman | Self | Board Member | 000 0000 |
Keith Leonard Jr. | Self | Chairman & Board Member | 000 0000 |
Sienna Biopharmaceuticals Signals
Sienna Biopharmaceuticals Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 | 06-Dec-2016 | 0000000000 | 00000 | Biotechnology |